Aurinia Pharmaceuticals Inc.
Profile
Mailing Address: 1203 - 4464 Markham Street
Victoria, BC
V8Z 7X8
Head Office Address: 1203 - 4464 Markham Street
Victoria, British Columbia
V8Z 7X8
Contact Name: Michael R. Martin Principal Regulator: British Columbia
Business e-mail address: mmartin@auriniapharma.com Short Form Prospectus Issuer: Yes
Telephone Number: 250 708-4272 Reporting Jurisdictions: British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland
Fax Number: 250 744-2498 Stock Exchange: TSX, NASDAQ
Date of Formation: Jan 1 2011 Stock Symbol: AUPH
Jurisdiction Where Formed: Alberta Auditor: PricewaterhouseCoopers LLP
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 05156V Transfer Agent: Computershare Trust Company of Canada
Financial Year-End: Dec 31 Size of Issuer (Assets): $25,000,001 to $100,000,000


View This Company's Documents